Literature DB >> 29173162

Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.

Vincent Blandino1, Jillian Wetzel1, Jiyoung Kim1, Petrit Haxhi1, Richard Curtis1, Marta Concheiro1.   

Abstract

BACKGROUND: Urine is a common biological sample to monitor recent drug exposure, and oral fluid is an alternative matrix of increasing interest in clinical and forensic toxicology. Limited data are available about oral fluid vs. urine drug disposition, especially for synthetic cannabinoids.
OBJECTIVE: To compare urine and oral fluid as biological matrices to monitor recent drug exposure among HIV-infected homeless individuals.
METHODS: Seventy matched urine and oral fluid samples were collected from 13 participants. Cannabis, amphetamines, benzodiazepines, cocaine and opiates were analyzed in urine by the enzyme-multipliedimmunoassay- technique and in oral fluid by liquid chromatography tandem mass spectrometry (LCMSMS). Eleven synthetic cannabinoids were analyzed in urine and in oral fluid by LC-MSMS.
RESULTS: Five oral fluid samples were positive for AB-FUBINACA. In urine, 4 samples tested positive for synthetic cannabinoids PB-22, 5-Fluoro-PB-22, AB-FUBINACA, and metabolites UR-144 5-pentanoic acid and UR-144 4-hydroxypentyl. In only one case, oral fluid and urine results matched, both specimens being AB-FUBINACA positive. For cannabis, 40 samples tested positive in urine and 30 in oral fluid (85.7% match). For cocaine, 37 urine and 52 oral fluid samples were positive (75.7% match). Twenty-four urine samples were positive for opiates, and 25 in oral fluid (81.4% match). For benzodiazepines, 23 samples were positive in urine and 25 in oral fluid (85.7% match). CONCLUSION/DISCUSSION: These results offer new information about drugs disposition between urine and oral fluid. Oral fluid is a good alternative matrix to urine for monitoring cannabis, cocaine, opiates and benzodiazepines recent use; however, synthetic cannabinoids showed mixed results. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Benzodiazepines; cannabis; cocaine; opiates; oral fluid; synthetic cannabinoids; urine

Mesh:

Substances:

Year:  2017        PMID: 29173162      PMCID: PMC5931376          DOI: 10.2174/1389201018666171122113934

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  30 in total

1.  Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.

Authors:  V Vindenes; H M E Lund; W Andresen; H Gjerde; S E Ikdahl; A S Christophersen; E L Øiestad
Journal:  Forensic Sci Int       Date:  2012-01-30       Impact factor: 2.395

Review 2.  Introduction and review of collection techniques and applications of drug testing of oral fluid.

Authors:  Olaf H Drummer
Journal:  Ther Drug Monit       Date:  2008-04       Impact factor: 3.681

Review 3.  Update of Standard Practices for New Method Validation in Forensic Toxicology.

Authors:  Sarah M R Wille; Wim Coucke; Thierry De Baere; Frank T Peters
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

4.  Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.

Authors:  Katie L Miller; Brandi L Puet; Ali Roberts; Cheryl Hild; Jason Carter; David L Black
Journal:  J Subst Abuse Treat       Date:  2017-01-25

5.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

6.  Effect of repeated cocaine administration on detection times in oral fluid and urine.

Authors:  Rebecca Jufer; Sharon L Walsh; Edward J Cone; Angela Sampson-Cone
Journal:  J Anal Toxicol       Date:  2006-09       Impact factor: 3.367

7.  Quantitative measurement of XLR11 and UR-144 in oral fluid by LC-MS-MS.

Authors:  Piyadarsha Amaratunga; Christopher Thomas; Bridget Lorenz Lemberg; Dave Lemberg
Journal:  J Anal Toxicol       Date:  2014-05-07       Impact factor: 3.367

8.  Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.

Authors:  H Reddon; M-J Milloy; A Simo; J Montaner; E Wood; T Kerr
Journal:  AIDS Behav       Date:  2014-04

9.  A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.

Authors:  Damon Borg; Anna Tverdovsky; Richard Stripp
Journal:  J Anal Toxicol       Date:  2016-09-27       Impact factor: 3.367

10.  Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?

Authors:  Nathalie A Desrosiers; Dayong Lee; Marta Concheiro-Guisan; Karl B Scheidweiler; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-11-01       Impact factor: 8.327

View more
  1 in total

1.  In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.

Authors:  Sunjoo Kim; Dong Kyun Kim; Yongho Shin; Ji-Hyeon Jeon; Im-Sook Song; Hye Suk Lee
Journal:  Molecules       Date:  2020-10-08       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.